Moreover, a marked increase in STEAP4 was obtained (8.9 -old), which is of interest as STEAP4 protein is found to be reduced in the liver of individuals with NAFLD, and overexpression in mice ameliorates liver steatosis and insulin resistance [35]. Here, STEAP4 is linked to metabolic dysfunction-associated steatotic liver disease.